ID   AOXA_HUMAN              Reviewed;        1338 AA.
AC   Q06278; O14765; Q53RR8; Q53TV3; Q9BYF0; Q9UPG6;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   12-APR-2017, entry version 170.
DE   RecName: Full=Aldehyde oxidase;
DE            EC=1.2.3.1 {ECO:0000269|PubMed:22996261, ECO:0000269|PubMed:9224775};
DE   AltName: Full=Aldehyde oxidase 1;
DE   AltName: Full=Azaheterocycle hydroxylase;
DE            EC=1.17.3.-;
GN   Name=AOX1; Synonyms=AO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=8248161; DOI=10.1073/pnas.90.22.10690;
RA   Wright R.M., Vaitaitis G.M., Wilson C.M., Repine T.B., Terada L.S.,
RA   Repine J.E.;
RT   "cDNA cloning, characterization, and tissue-specific expression of
RT   human xanthine dehydrogenase/xanthine oxidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10690-10694(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Wright R.M., Weigel L.K., Varella-Garcia M., Vaitaitis G.,
RA   Repine J.E.;
RT   "Molecular cloning, refined chromosomal mapping, and structural
RT   analysis of the human gene encoding aldehyde oxidase (AOX1), a
RT   candidate for the ALS2 gene.";
RL   Redox Rep. 3:135-144(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=11302742; DOI=10.1006/bbrc.2001.4719;
RA   Ichida K., Matsumura T., Sakuma R., Hosoya T., Nishino T.;
RT   "Mutation of human molybdenum cofactor sulfurase gene is responsible
RT   to classical xanthinuria type II.";
RL   Biochem. Biophys. Res. Commun. 282:1194-1200(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, AND SUBSTRATE SPECIFICITY.
RX   PubMed=7786031; DOI=10.1006/abbi.1995.1320;
RA   Beedham C., Critchley D.J., Rance D.J.;
RT   "Substrate specificity of human liver aldehyde oxidase toward
RT   substituted quinazolines and phthalazines: a comparison with hepatic
RT   enzyme from guinea pig, rabbit, and baboon.";
RL   Arch. Biochem. Biophys. 319:481-490(1995).
RN   [8]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9224775;
RA   Rashidi M.R., Smith J.A., Clarke S.E., Beedham C.;
RT   "In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde
RT   oxidase from human, guinea pig, rabbit, and rat liver.";
RL   Drug Metab. Dispos. 25:805-813(1997).
RN   [9]
RP   INDUCTION.
RX   PubMed=17022944; DOI=10.1016/j.bbrc.2006.09.101;
RA   Neumeier M., Weigert J., Schaeffler A., Weiss T.S., Schmidl C.,
RA   Buettner R., Bollheimer C., Aslanidis C., Schoelmerich J.,
RA   Buechler C.;
RT   "Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is
RT   down-regulated by adiponectin and fenofibric acid in hepatocytes in
RT   vitro.";
RL   Biochem. Biophys. Res. Commun. 350:731-735(2006).
RN   [10]
RP   REVIEW, NOMENCLATURE, AND TISSUE SPECIFICITY.
RX   PubMed=18066686; DOI=10.1007/s00018-007-7398-y;
RA   Garattini E., Fratelli M., Terao M.;
RT   "Mammalian aldehyde oxidases: genetics, evolution and biochemistry.";
RL   Cell. Mol. Life Sci. 65:1019-1048(2008).
RN   [11]
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=18671973; DOI=10.1016/j.febslet.2008.07.034;
RA   Weigert J., Neumeier M., Bauer S., Mages W., Schnitzbauer A.A.,
RA   Obed A., Groeschl B., Hartmann A., Schaeffler A., Aslanidis C.,
RA   Schoelmerich J., Buechler C.;
RT   "Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in
RT   3T3-L1 cells impairs adipogenesis and adiponectin release.";
RL   FEBS Lett. 582:2965-2972(2008).
RN   [12]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, SUBSTRATE SPECIFICITY, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=20444863; DOI=10.1124/dmd.110.033555;
RA   Zientek M., Jiang Y., Youdim K., Obach R.S.;
RT   "In vitro-in vivo correlation for intrinsic clearance for drugs
RT   metabolized by human aldehyde oxidase.";
RL   Drug Metab. Dispos. 38:1322-1327(2010).
RN   [13]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, ENZYME REGULATION, SUBSTRATE
RP   SPECIFICITY, AND TISSUE SPECIFICITY.
RX   PubMed=22031625; DOI=10.1124/dmd.111.042861;
RA   Hutzler J.M., Yang Y.S., Albaugh D., Fullenwider C.L., Schmenk J.,
RA   Fisher M.B.;
RT   "Characterization of aldehyde oxidase enzyme activity in cryopreserved
RT   human hepatocytes.";
RL   Drug Metab. Dispos. 40:267-275(2012).
RN   [14]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, ENZYME REGULATION, SUBSTRATE
RP   SPECIFICITY, AND TISSUE SPECIFICITY.
RX   PubMed=22522748; DOI=10.1124/dmd.112.045195;
RA   Strelevitz T.J., Orozco C.C., Obach R.S.;
RT   "Hydralazine as a selective probe inactivator of aldehyde oxidase in
RT   human hepatocytes: estimation of the contribution of aldehyde oxidase
RT   to metabolic clearance.";
RL   Drug Metab. Dispos. 40:1441-1448(2012).
RN   [15]
RP   REVIEW.
RX   PubMed=22335465; DOI=10.1517/17425255.2012.663352;
RA   Garattini E., Terao M.;
RT   "The role of aldehyde oxidase in drug metabolism.";
RL   Expert Opin. Drug Metab. Toxicol. 8:487-503(2012).
RN   [16]
RP   FUNCTION AS AZAHETEROCYCLE OXIDASE, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22996261; DOI=10.1124/dmd.112.048546;
RA   Barr J.T., Jones J.P.;
RT   "Evidence for substrate-dependent inhibition profiles for human liver
RT   aldehyde oxidase.";
RL   Drug Metab. Dispos. 41:24-29(2013).
RN   [17]
RP   FUNCTION AS DRUG-METABOLIZING ENZYME, SUBSTRATE SPECIFICITY, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=23857892; DOI=10.1124/dmd.113.053082;
RA   Fu C., Di L., Han X., Soderstrom C., Snyder M., Troutman M.D.,
RA   Obach R.S., Zhang H.;
RT   "Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative
RT   characterization of AOX1 expression level and activity relationship.";
RL   Drug Metab. Dispos. 41:1797-1804(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1068, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   VARIANTS CYS-802; HIS-921; SER-1135; LEU-1271 AND ARG-1297,
RP   CHARACTERIZATION OF VARIANTS CYS-802; HIS-921; SER-1135 AND ARG-1297,
RP   FUNCTION AS OXIDASE, HOMODIMER, COFACTOR, SUBSTRATE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22279051; DOI=10.1124/dmd.111.043828;
RA   Hartmann T., Terao M., Garattini E., Teutloff C., Alfaro J.F.,
RA   Jones J.P., Leimkuehler S.;
RT   "The impact of single nucleotide polymorphisms on human aldehyde
RT   oxidase.";
RL   Drug Metab. Dispos. 40:856-864(2012).
CC   -!- FUNCTION: Oxidase with broad substrate specificity, oxidizing
CC       aromatic azaheterocycles, such as N1-methylnicotinamide and N-
CC       methylphthalazinium, as well as aldehydes, such as benzaldehyde,
CC       retinal, pyridoxal, and vanillin. Plays a key role in the
CC       metabolism of xenobiotics and drugs containing aromatic
CC       azaheterocyclic substituents. Participates in the bioactivation of
CC       prodrugs such as famciclovir, catalyzing the oxidation step from
CC       6-deoxypenciclovir to penciclovir, which is a potent antiviral
CC       agent. Is probably involved in the regulation of reactive oxygen
CC       species homeostasis. May be a prominent source of superoxide
CC       generation via the one-electron reduction of molecular oxygen.
CC       Also may catalyze nitric oxide (NO) production via the reduction
CC       of nitrite to NO with NADH or aldehyde as electron donor. May play
CC       a role in adipogenesis. {ECO:0000269|PubMed:20444863,
CC       ECO:0000269|PubMed:22031625, ECO:0000269|PubMed:22279051,
CC       ECO:0000269|PubMed:22522748, ECO:0000269|PubMed:22996261,
CC       ECO:0000269|PubMed:23857892, ECO:0000269|PubMed:7786031,
CC       ECO:0000269|PubMed:9224775}.
CC   -!- CATALYTIC ACTIVITY: An aldehyde + H(2)O + O(2) = a carboxylate +
CC       H(2)O(2). {ECO:0000269|PubMed:22996261,
CC       ECO:0000269|PubMed:9224775}.
CC   -!- CATALYTIC ACTIVITY: Retinal + O(2) + H(2)O = retinoate + H(2)O(2).
CC       {ECO:0000250|UniProtKB:O54754}.
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601;
CC         Evidence={ECO:0000269|PubMed:22279051};
CC       Note=Binds 2 [2Fe-2S] clusters per subunit.
CC       {ECO:0000269|PubMed:22279051};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:22279051};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:22279051};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000269|PubMed:22279051};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000269|PubMed:22279051};
CC   -!- ENZYME REGULATION: Is very potently inhibited by raloxifene. Also
CC       inhibited by estradiol, ethinyl estradiol, hydralazine, menadione,
CC       and isovanillin. Not inhibited by allopurinol, a xanthine
CC       dehydrogenase potent inhibitor. {ECO:0000269|PubMed:22031625,
CC       ECO:0000269|PubMed:22522748, ECO:0000269|PubMed:22996261,
CC       ECO:0000269|PubMed:9224775}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7.1 uM for benzaldehyde (at 25 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         KM=1.3 uM for phthalazine (at 25 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         KM=3.9 uM for phenanthridine (at 25 degrees Celsius and pH 7.5)
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         KM=5.2 uM for chloroquinazolinone (at 25 degrees Celsius and pH
CC         7.5) {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         KM=0.42 mM for 6-deoxypenciclovir (at 37 degrees Celsius and pH
CC         7) {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         KM=0.15 mM for famciclovir (at 37 degrees Celsius and pH 7)
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         KM=6.3 uM for N-[(2-dimethylamino)ethyl]acridine-4-carboxamide
CC         (at 37 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:22279051,
CC         ECO:0000269|PubMed:22996261, ECO:0000269|PubMed:9224775};
CC         Vmax=16 nmol/min/mg enzyme with 6-deoxypenciclovir as substrate
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         Vmax=61 nmol/min/mg enzyme with famciclovir as substrate
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         Vmax=2.3 nmol/min/mg enzyme with N-[(2-
CC         dimethylamino)ethyl]acridine-4-carboxamide as substrate
CC         {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:22996261,
CC         ECO:0000269|PubMed:9224775};
CC         Note=kcat is 6.4 min(-1) for benzaldehyde oxidation, 5.6 min(-1)
CC         for phthalazine oxidation, 12.2 min(-1) for phenanthridine
CC         oxidation and 5.6 min(-1) for chloroquinazolinone oxidation.;
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18671973,
CC       ECO:0000269|PubMed:20444863, ECO:0000269|PubMed:23857892}.
CC   -!- TISSUE SPECIFICITY: Abundant in liver, expressed in adipose tissue
CC       and at lower levels in lung, skeletal muscle, pancreas. In
CC       contrast to mice, no significant gender difference in AOX1
CC       expression level (at protein level). {ECO:0000269|PubMed:18066686,
CC       ECO:0000269|PubMed:18671973, ECO:0000269|PubMed:20444863,
CC       ECO:0000269|PubMed:22031625, ECO:0000269|PubMed:22522748,
CC       ECO:0000269|PubMed:23857892, ECO:0000269|PubMed:8248161}.
CC   -!- DEVELOPMENTAL STAGE: Not detected in preadipocytes but strongly
CC       induced in mature adipocytes. {ECO:0000269|PubMed:18671973}.
CC   -!- INDUCTION: In liver, is down-regulated by adiponectin and by the
CC       PPARA agonist, fenofibric acid. {ECO:0000269|PubMed:17022944}.
CC   -!- MISCELLANEOUS: AOX genes evolved from a xanthine oxidoreductase
CC       ancestral precursor via a series of gene duplication and
CC       suppression/deletion events. Different animal species contain a
CC       different complement of AOX genes encoding an equivalent number of
CC       AOX isoenzymes. In mammals, the two extremes are represented by
CC       certain rodents such as mice and rats, which are endowed with 4
CC       AOX genes, and by humans, whose genome is characterized by a
CC       single active gene (PubMed:22335465).
CC       {ECO:0000305|PubMed:22335465}.
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a xanthine dehydrogenase.
CC       {ECO:0000305|PubMed:8248161}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA96650.1; Type=Frameshift; Positions=284, 286, 294, 302; Evidence={ECO:0000305};
CC       Sequence=AAB83966.1; Type=Frameshift; Positions=284, 286, 294, 302; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L11005; AAA96650.1; ALT_FRAME; mRNA.
DR   EMBL; AF017060; AAB83966.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AF009441; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009442; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009443; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009444; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009445; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009446; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009447; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009448; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009449; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009450; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009451; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009452; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009453; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009454; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009455; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009456; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009457; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009458; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009459; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009460; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009461; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009462; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009463; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009464; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009465; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009466; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009467; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009468; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009469; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009470; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009471; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009472; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009473; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF009474; AAB83966.1; JOINED; Genomic_DNA.
DR   EMBL; AF010260; AAB83968.1; -; Genomic_DNA.
DR   EMBL; AB046692; BAB40305.1; -; mRNA.
DR   EMBL; AC007163; AAX93285.1; -; Genomic_DNA.
DR   EMBL; AC080164; AAY24265.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70209.1; -; Genomic_DNA.
DR   EMBL; BC117179; AAI17180.1; -; mRNA.
DR   EMBL; BC117181; AAI17182.1; -; mRNA.
DR   CCDS; CCDS33360.1; -.
DR   PIR; A49634; A49634.
DR   RefSeq; NP_001150.3; NM_001159.3.
DR   UniGene; Hs.406238; -.
DR   PDB; 4UHW; X-ray; 2.60 A; A=1-1338.
DR   PDB; 4UHX; X-ray; 2.70 A; A=1-1338.
DR   PDB; 5EPG; X-ray; 3.39 A; A=1-1338.
DR   PDBsum; 4UHW; -.
DR   PDBsum; 4UHX; -.
DR   PDBsum; 5EPG; -.
DR   ProteinModelPortal; Q06278; -.
DR   SMR; Q06278; -.
DR   BioGrid; 106813; 6.
DR   DIP; DIP-61698N; -.
DR   IntAct; Q06278; 4.
DR   STRING; 9606.ENSP00000363832; -.
DR   BindingDB; Q06278; -.
DR   ChEMBL; CHEMBL3257; -.
DR   DrugBank; DB00437; Allopurinol.
DR   DrugBank; DB00513; Aminocaproic Acid.
DR   DrugBank; DB00484; Brimonidine.
DR   DrugBank; DB03516; Eniluracil.
DR   DrugBank; DB04827; Ethyl carbamate.
DR   DrugBank; DB00426; Famciclovir.
DR   DrugBank; DB09054; Idelalisib.
DR   DrugBank; DB09078; Lenvatinib.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB01033; Mercaptopurine.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00339; Pyrazinamide.
DR   DrugBank; DB00481; Raloxifene.
DR   DrugBank; DB00962; Zaleplon.
DR   DrugBank; DB00909; Zonisamide.
DR   iPTMnet; Q06278; -.
DR   PhosphoSitePlus; Q06278; -.
DR   BioMuta; AOX1; -.
DR   DMDM; 215273968; -.
DR   EPD; Q06278; -.
DR   MaxQB; Q06278; -.
DR   PaxDb; Q06278; -.
DR   PeptideAtlas; Q06278; -.
DR   PRIDE; Q06278; -.
DR   Ensembl; ENST00000374700; ENSP00000363832; ENSG00000138356.
DR   GeneID; 316; -.
DR   KEGG; hsa:316; -.
DR   UCSC; uc002uvx.4; human.
DR   CTD; 316; -.
DR   DisGeNET; 316; -.
DR   GeneCards; AOX1; -.
DR   H-InvDB; HIX0029780; -.
DR   HGNC; HGNC:553; AOX1.
DR   HPA; HPA040199; -.
DR   HPA; HPA040215; -.
DR   MIM; 602841; gene.
DR   neXtProt; NX_Q06278; -.
DR   OpenTargets; ENSG00000138356; -.
DR   PharmGKB; PA24842; -.
DR   eggNOG; KOG0430; Eukaryota.
DR   eggNOG; COG4630; LUCA.
DR   eggNOG; COG4631; LUCA.
DR   GeneTree; ENSGT00390000003772; -.
DR   HOGENOM; HOG000191197; -.
DR   HOVERGEN; HBG004182; -.
DR   InParanoid; Q06278; -.
DR   KO; K00157; -.
DR   OMA; MDPVHYP; -.
DR   OrthoDB; EOG091G01AW; -.
DR   PhylomeDB; Q06278; -.
DR   TreeFam; TF353036; -.
DR   BioCyc; MetaCyc:ENSG00000138356-MONOMER; -.
DR   BRENDA; 1.2.3.1; 2681.
DR   Reactome; R-HSA-964975; Vitamins B6 activation to pyridoxal phosphate.
DR   SABIO-RK; Q06278; -.
DR   ChiTaRS; AOX1; human.
DR   GeneWiki; Aldehyde_oxidase_1; -.
DR   GenomeRNAi; 316; -.
DR   PRO; PR:Q06278; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138356; -.
DR   CleanEx; HS_AOX1; -.
DR   ExpressionAtlas; Q06278; baseline and differential.
DR   Genevisible; Q06278; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0004031; F:aldehyde oxidase activity; TAS:Reactome.
DR   GO; GO:0009055; F:electron carrier activity; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IEA:InterPro.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0016614; F:oxidoreductase activity, acting on CH-OH group of donors; IEA:InterPro.
DR   GO; GO:0016903; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors; IBA:GO_Central.
DR   GO; GO:0004854; F:xanthine dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; TAS:ProtInc.
DR   GO; GO:0042816; P:vitamin B6 metabolic process; TAS:Reactome.
DR   GO; GO:0009115; P:xanthine catabolic process; IBA:GO_Central.
DR   Gene3D; 1.10.150.120; -; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.30.365.10; -; 4.
DR   Gene3D; 3.30.43.10; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   Gene3D; 3.90.1170.50; -; 1.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH.
DR   InterPro; IPR014313; Aldehyde_oxidase.
DR   InterPro; IPR008274; AldOxase/xan_DH_Mopterin-bd.
DR   InterPro; IPR012675; Beta-grasp_dom.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR016169; CO_DH_flavot_FAD-bd_sub2.
DR   InterPro; IPR016166; FAD-bd_2.
DR   InterPro; IPR016167; FAD-bd_2_sub1.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF02738; Ald_Xan_dh_C2; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF47741; SSF47741; 1.
DR   SUPFAM; SSF54292; SSF54292; 1.
DR   SUPFAM; SSF54665; SSF54665; 1.
DR   SUPFAM; SSF55447; SSF55447; 1.
DR   SUPFAM; SSF56003; SSF56003; 1.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   TIGRFAMs; TIGR02969; mam_aldehyde_ox; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; 3D-structure; Complete proteome; Cytoplasm; FAD; Flavoprotein;
KW   Iron; Iron-sulfur; Metal-binding; Molybdenum; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   1338       Aldehyde oxidase.
FT                                /FTId=PRO_0000166104.
FT   DOMAIN        5     92       2Fe-2S ferredoxin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00465}.
FT   DOMAIN      236    421       FAD-binding PCMH-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00718}.
FT   NP_BIND     264    271       FAD. {ECO:0000250}.
FT   ACT_SITE   1270   1270       Proton acceptor; for azaheterocycle
FT                                hydroxylase activity. {ECO:0000250}.
FT   METAL        44     44       Iron-sulfur 1 (2Fe-2S). {ECO:0000250}.
FT   METAL        49     49       Iron-sulfur 1 (2Fe-2S). {ECO:0000250}.
FT   METAL        52     52       Iron-sulfur 1 (2Fe-2S). {ECO:0000250}.
FT   METAL        74     74       Iron-sulfur 1 (2Fe-2S). {ECO:0000250}.
FT   METAL       114    114       Iron-sulfur 2 (2Fe-2S). {ECO:0000250}.
FT   METAL       117    117       Iron-sulfur 2 (2Fe-2S). {ECO:0000250}.
FT   METAL       149    149       Iron-sulfur 2 (2Fe-2S). {ECO:0000250}.
FT   METAL       151    151       Iron-sulfur 2 (2Fe-2S). {ECO:0000250}.
FT   BINDING     113    113       Molybdopterin. {ECO:0000250}.
FT   BINDING     354    354       FAD. {ECO:0000250}.
FT   BINDING     358    358       FAD. {ECO:0000250}.
FT   BINDING     367    367       FAD. {ECO:0000250}.
FT   BINDING     411    411       FAD; via amide nitrogen. {ECO:0000250}.
FT   BINDING     806    806       Molybdopterin; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING    1047   1047       Molybdopterin; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING    1203   1203       Molybdopterin. {ECO:0000250}.
FT   MOD_RES    1068   1068       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     314    314       Q -> R (in dbSNP:rs58185012).
FT                                /FTId=VAR_061136.
FT   VARIANT     802    802       R -> C (decreases homodimerization but
FT                                nearly no effect on kinetic parameters;
FT                                dbSNP:rs41309768).
FT                                {ECO:0000269|PubMed:22279051}.
FT                                /FTId=VAR_047517.
FT   VARIANT     921    921       R -> H (increases homodimerization;
FT                                abolishes enzymatic activity on
FT                                phenanthridine; decreases turnover number
FT                                with benzaldehyde, phtalazine and
FT                                chloroquinazolinone as substrate, while
FT                                nearly no effect on the KM;
FT                                dbSNP:rs56199635).
FT                                {ECO:0000269|PubMed:22279051}.
FT                                /FTId=VAR_070256.
FT   VARIANT    1135   1135       N -> S (increases homodimerization and
FT                                turnover number with phenanthridine as
FT                                substrate; nearly no effect on kinetic
FT                                parameters with benzaldehyde, phtalazine
FT                                and chloroquinazolinone as substrate;
FT                                dbSNP:rs55754655).
FT                                {ECO:0000269|PubMed:22279051}.
FT                                /FTId=VAR_070257.
FT   VARIANT    1271   1271       S -> L (in dbSNP:rs141786030).
FT                                {ECO:0000269|PubMed:22279051}.
FT                                /FTId=VAR_070258.
FT   VARIANT    1297   1297       H -> R (increases homodimerization and
FT                                turnover number with phenanthridine as
FT                                substrate; nearly no effect on kinetic
FT                                parameters with benzaldehyde, phtalazine
FT                                and chloroquinazolinone as substrate;
FT                                dbSNP:rs3731722).
FT                                {ECO:0000269|PubMed:22279051}.
FT                                /FTId=VAR_047518.
FT   CONFLICT     41     41       K -> P (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   CONFLICT    127    127       T -> P (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   CONFLICT    152    152       T -> H (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   CONFLICT    227    227       E -> D (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   CONFLICT    251    251       E -> D (in Ref. 1; AAA96650).
FT                                {ECO:0000305}.
FT   CONFLICT    418    418       Y -> I (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   CONFLICT    501    501       V -> L (in Ref. 2; AAB83966).
FT                                {ECO:0000305}.
FT   CONFLICT    627    627       I -> N (in Ref. 2; AAB83966).
FT                                {ECO:0000305}.
FT   CONFLICT    929    929       A -> V (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   CONFLICT   1019   1019       G -> A (in Ref. 1; AAA96650 and 2;
FT                                AAB83966). {ECO:0000305}.
FT   STRAND        6     11       {ECO:0000244|PDB:4UHW}.
FT   STRAND       14     20       {ECO:0000244|PDB:4UHW}.
FT   HELIX        27     33       {ECO:0000244|PDB:4UHW}.
FT   STRAND       45     49       {ECO:0000244|PDB:4UHW}.
FT   STRAND       53     60       {ECO:0000244|PDB:4UHW}.
FT   TURN         61     64       {ECO:0000244|PDB:4UHW}.
FT   STRAND       65     72       {ECO:0000244|PDB:4UHW}.
FT   HELIX        73     75       {ECO:0000244|PDB:4UHW}.
FT   HELIX        78     81       {ECO:0000244|PDB:4UHW}.
FT   STRAND       85     87       {ECO:0000244|PDB:4UHW}.
FT   HELIX        89     92       {ECO:0000244|PDB:4UHW}.
FT   STRAND       95     97       {ECO:0000244|PDB:4UHX}.
FT   HELIX       101    108       {ECO:0000244|PDB:4UHW}.
FT   HELIX       118    131       {ECO:0000244|PDB:4UHW}.
FT   HELIX       137    143       {ECO:0000244|PDB:4UHW}.
FT   HELIX       144    146       {ECO:0000244|PDB:4UHW}.
FT   STRAND      150    152       {ECO:0000244|PDB:4UHW}.
FT   HELIX       155    162       {ECO:0000244|PDB:4UHW}.
FT   HELIX       204    206       {ECO:0000244|PDB:4UHW}.
FT   HELIX       212    214       {ECO:0000244|PDB:4UHX}.
FT   HELIX       220    226       {ECO:0000244|PDB:4UHW}.
FT   STRAND      234    237       {ECO:0000244|PDB:4UHW}.
FT   STRAND      242    245       {ECO:0000244|PDB:4UHW}.
FT   HELIX       249    258       {ECO:0000244|PDB:4UHW}.
FT   HELIX       271    277       {ECO:0000244|PDB:4UHW}.
FT   STRAND      283    286       {ECO:0000244|PDB:4UHW}.
FT   HELIX       292    295       {ECO:0000244|PDB:4UHW}.
FT   STRAND      297    299       {ECO:0000244|PDB:4UHW}.
FT   STRAND      301    307       {ECO:0000244|PDB:4UHW}.
FT   HELIX       312    325       {ECO:0000244|PDB:4UHW}.
FT   TURN        328    330       {ECO:0000244|PDB:4UHX}.
FT   HELIX       332    343       {ECO:0000244|PDB:4UHW}.
FT   HELIX       347    352       {ECO:0000244|PDB:4UHW}.
FT   HELIX       355    361       {ECO:0000244|PDB:4UHW}.
FT   HELIX       369    374       {ECO:0000244|PDB:4UHW}.
FT   STRAND      378    382       {ECO:0000244|PDB:4UHW}.
FT   STRAND      387    391       {ECO:0000244|PDB:4UHW}.
FT   HELIX       394    397       {ECO:0000244|PDB:4UHW}.
FT   TURN        401    403       {ECO:0000244|PDB:4UHW}.
FT   STRAND      410    417       {ECO:0000244|PDB:4UHW}.
FT   STRAND      423    430       {ECO:0000244|PDB:4UHW}.
FT   STRAND      432    437       {ECO:0000244|PDB:4UHW}.
FT   STRAND      440    448       {ECO:0000244|PDB:4UHW}.
FT   STRAND      451    453       {ECO:0000244|PDB:4UHW}.
FT   STRAND      458    469       {ECO:0000244|PDB:4UHW}.
FT   HELIX       474    480       {ECO:0000244|PDB:4UHW}.
FT   HELIX       487    498       {ECO:0000244|PDB:4UHW}.
FT   HELIX       512    537       {ECO:0000244|PDB:4UHW}.
FT   TURN        539    541       {ECO:0000244|PDB:4UHW}.
FT   TURN        547    549       {ECO:0000244|PDB:4UHW}.
FT   HELIX       550    552       {ECO:0000244|PDB:4UHW}.
FT   STRAND      562    566       {ECO:0000244|PDB:4UHW}.
FT   STRAND      572    574       {ECO:0000244|PDB:4UHX}.
FT   HELIX       589    593       {ECO:0000244|PDB:4UHW}.
FT   HELIX       600    602       {ECO:0000244|PDB:4UHW}.
FT   STRAND      610    616       {ECO:0000244|PDB:4UHW}.
FT   STRAND      620    628       {ECO:0000244|PDB:4UHW}.
FT   HELIX       630    633       {ECO:0000244|PDB:4UHW}.
FT   STRAND      638    642       {ECO:0000244|PDB:4UHW}.
FT   HELIX       644    646       {ECO:0000244|PDB:4UHW}.
FT   HELIX       648    650       {ECO:0000244|PDB:4UHW}.
FT   STRAND      666    668       {ECO:0000244|PDB:4UHW}.
FT   STRAND      674    682       {ECO:0000244|PDB:4UHW}.
FT   HELIX       683    690       {ECO:0000244|PDB:4UHW}.
FT   STRAND      694    699       {ECO:0000244|PDB:4UHW}.
FT   HELIX       709    711       {ECO:0000244|PDB:4UHW}.
FT   STRAND      721    726       {ECO:0000244|PDB:4UHW}.
FT   HELIX       728    731       {ECO:0000244|PDB:4UHW}.
FT   HELIX       732    734       {ECO:0000244|PDB:4UHW}.
FT   STRAND      736    745       {ECO:0000244|PDB:4UHW}.
FT   STRAND      756    762       {ECO:0000244|PDB:4UHW}.
FT   STRAND      769    773       {ECO:0000244|PDB:4UHW}.
FT   HELIX       778    789       {ECO:0000244|PDB:4UHW}.
FT   HELIX       793    795       {ECO:0000244|PDB:4UHW}.
FT   STRAND      796    801       {ECO:0000244|PDB:4UHW}.
FT   HELIX       812    828       {ECO:0000244|PDB:4UHW}.
FT   STRAND      832    835       {ECO:0000244|PDB:4UHW}.
FT   HELIX       838    844       {ECO:0000244|PDB:4UHW}.
FT   STRAND      851    859       {ECO:0000244|PDB:4UHW}.
FT   STRAND      865    878       {ECO:0000244|PDB:4UHW}.
FT   HELIX       884    893       {ECO:0000244|PDB:4UHW}.
FT   TURN        894    897       {ECO:0000244|PDB:4UHW}.
FT   STRAND      901    911       {ECO:0000244|PDB:4UHW}.
FT   TURN        921    924       {ECO:0000244|PDB:4UHW}.
FT   HELIX       925    943       {ECO:0000244|PDB:4UHW}.
FT   HELIX       947    954       {ECO:0000244|PDB:4UHW}.
FT   STRAND      958    961       {ECO:0000244|PDB:4UHW}.
FT   STRAND      967    969       {ECO:0000244|PDB:4UHW}.
FT   HELIX       971    984       {ECO:0000244|PDB:4UHW}.
FT   HELIX       986    999       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1001   1016       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1022   1024       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1026   1032       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1038   1043       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1047   1049       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1051   1062       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1067   1069       {ECO:0000244|PDB:4UHW}.
FT   TURN       1077   1079       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1091   1115       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1122   1131       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1137   1142       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1148   1150       {ECO:0000244|PDB:4UHW}.
FT   TURN       1151   1154       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1155   1157       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1160   1174       {ECO:0000244|PDB:4UHW}.
FT   TURN       1175   1177       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1180   1190       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1197   1215       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1232   1234       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1241   1243       {ECO:0000244|PDB:4UHW}.
FT   STRAND     1246   1252       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1262   1264       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1271   1276       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1277   1293       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1308   1314       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1318   1322       {ECO:0000244|PDB:4UHW}.
FT   HELIX      1328   1330       {ECO:0000244|PDB:4UHW}.
SQ   SEQUENCE   1338 AA;  147918 MW;  2AB5E543F18C9261 CRC64;
     MDRASELLFY VNGRKVIEKN VDPETMLLPY LRKKLRLTGT KYGCGGGGCG ACTVMISRYN
     PITKRIRHHP ANACLIPICS LYGAAVTTVE GIGSTHTRIH PVQERIAKCH GTQCGFCTPG
     MVMSIYTLLR NHPEPTLDQL TDALGGNLCR CTGYRPIIDA CKTFCKTSGC CQSKENGVCC
     LDQGINGLPE FEEGSKTSPK LFAEEEFLPL DPTQELIFPP ELMIMAEKQS QRTRVFGSER
     MMWFSPVTLK ELLEFKFKYP QAPVIMGNTS VGPEVKFKGV FHPVIISPDR IEELSVVNHA
     YNGLTLGAGL SLAQVKDILA DVVQKLPEEK TQMYHALLKH LGTLAGSQIR NMASLGGHII
     SRHPDSDLNP ILAVGNCTLN LLSKEGKRQI PLNEQFLSKC PNADLKPQEI LVSVNIPYSR
     KWEFVSAFRQ AQRQENALAI VNSGMRVFFG EGDGIIRELC ISYGGVGPAT ICAKNSCQKL
     IGRHWNEQML DIACRLILNE VSLLGSAPGG KVEFKRTLII SFLFKFYLEV SQILKKMDPV
     HYPSLADKYE SALEDLHSKH HCSTLKYQNI GPKQHPEDPI GHPIMHLSGV KHATGEAIYC
     DDMPLVDQEL FLTFVTSSRA HAKIVSIDLS EALSMPGVVD IMTAEHLSDV NSFCFFTEAE
     KFLATDKVFC VGQLVCAVLA DSEVQAKRAA KRVKIVYQDL EPLILTIEES IQHNSSFKPE
     RKLEYGNVDE AFKVVDQILE GEIHMGGQEH FYMETQSMLV VPKGEDQEMD VYVSTQFPKY
     IQDIVASTLK LPANKVMCHV RRVGGAFGGK VLKTGIIAAV TAFAANKHGR AVRCVLERGE
     DMLITGGRHP YLGKYKAGFM NDGRILALDM EHYSNAGASL DESLFVIEMG LLKMDNAYKF
     PNLRCRGWAC RTNLPSNTAF RGFGFPQAAL ITESCITEVA AKCGLSPEKV RIINMYKEID
     QTPYKQEINA KNLIQCWREC MAMSSYSLRK VAVEKFNAEN YWKKKGLAMV PLKFPVGLGS
     RAAGQAAALV HIYLDGSVLV THGGIEMGQG VHTKMIQVVS RELRMPMSNV HLRGTSTETV
     PNANISGGSV VADLNGLAVK DACQTLLKRL EPIISKNPKG TWKDWAQTAF DESINLSAVG
     YFRGYESDMN WEKGEGQPFE YFVYGAACSE VEIDCLTGDH KNIRTDIVMD VGCSINPAID
     IGQIEGAFIQ GMGLYTIEEL NYSPQGILHT RGPDQYKIPA ICDMPTELHI ALLPPSQNSN
     TLYSSKGLGE SGVFLGCSVF FAIHDAVSAA RQERGLHGPL TLNSPLTPEK IRMACEDKFT
     KMIPRDEPGS YVPWNVPI
//
